retatrutide legal Availability and Current Status: UK Regulatory Guide – Bolt Pharmacy Demand for Unapproved Weight-Loss Drug

If you need treatment now, semaglutide and tirzepatide are excellent options with strong data behind them

Psychiatry 106, 574578

The percentage of patients who discontinued due to ineffective therapy was 3.0% in the liraglutide injection 1.8 mg + glimepiride treatment group, 3.5% in the liraglutide injection 1.2 mg + glimepiride treatment group, 17.5% in the placebo + glimepiride treatment group, and 6.9% in the rosiglitazone + glimepiride treatment group

Br J Pharmacol 179(4):492510

In addition, GLP-1 inhibits glucagon release (which slows down the release of sugar into the blood so that you burn more fat), slows down gastric emptying (makes you feel full), and lowers the desire for food intake (because you feel full)